The clinical effect of Silodosin for lower urinary tract symptoms after permanent prostate brachytherapy
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000004146
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with allergy against Silodocin. Patient with neurogenic bladder, bladder neck constructure, urethral stenosis, vesical stone, or large bladder diverticulum. Patient with active urinary tract infection. Patient with severe renal dysfunction. Patient with severe liver disease. Patient who is considered to be inapropriate for this study by physisian.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IPSS score, QOL score, OABSS score, IIEF-5 score, SF-8 score, EPIC score, Uroflowmetry Qmax
- Secondary Outcome Measures
Name Time Method safety